Kraig Biocraft Laboratories Inc (KBLB)

[fza]

Here's another that mentions spidersilk. Dec. of 2022

https://pubmed.ncbi.nlm.nih.gov/36556206/


2022 Dec 1;12(12):1986.
doi: 10.3390/jpm12121986.
In Vitro Differentiation of Myoblast Cell Lines on Spider Silk Scaffolds in a Rotating Bioreactor for Vascular Tissue Engineering
Doha Obed 1 , Nadjib Dastagir 1 , Christina Liebsch 1 , Alperen S Bingoel 1 , Sarah Strauss 1 , Peter M Vogt 1 , Khaled Dastagir 1
Affiliations

PMID: 36556206 PMCID: PMC9783533 DOI: 10.3390/jpm12121986

Free PMC article
Abstract

Functional construction of tissue-engineered vessels as an alternative to autologous vascular grafts has been shown to be feasible, however the proliferation of seeded smooth-muscle cells remains a limiting factor. We employed a rotating bioreactor system to improve myoblast cell differentiation on a spider silk scaffold for tissue-engineered vessel construction. C2C12 myofibroblast cells were seeded on the surface of spider silk scaffold constructs and cultivated in a rotating bioreactor system with a continuous rotation speed (1 rpm). Cell function, cell growth and morphological structure and expression of biomarkers were analyzed using scanning electron microscopy, the LIVE/DEAD® assay, Western blot and quantitative real-time PCR analyses. A dense myofibroblast cell sheet could be developed which resembled native blood vessel muscular tissue in morphological structure and in function. Bioreactor perfusion positively affected cell morphology, and increased cell viability and cell differentiation. The expression of desmin, MYF5 and MEF2D surged as an indication of myoblast differentiation. Cell-seeded scaffolds showed a tear-down at 18 N when strained at a set speed (20 mm min-1). Spider silk scaffolds appear to offer a reliable basis for engineered vascular constructs and rotating bioreactor cultivation may be considered an effective alternative to complex bioreactor setups to improve cell viability and biology.

Keywords: cell differentiation; myoblast; scaffolds; spider silk; tissue engineering; vascular tissue engineering.
Conflict of interest statement

The authors declare no conflict of interest.